FDA accepts 1st In Silico Drug Development Tool.Why GLP-1’s got more affordable.BALANCE after CMS GLP-1 decision.How to socialize scientific ideas in the age of AI.Mapping the Ebola outbreak.1985-2023: MIT’s faculty grew 9%…Administrative staff grew 189%
June 4, 2026
- Healthcare Economist Weekly Reader
- Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices
- Elimination of Federal Diversity Initiatives: Updates and Current Status
- Crothall Healthcare EVS Team Member Recognized as “Team Member of the Year” at Allegheny Health Network
Headlines
